Ocular toxicity of beta-blockers and benzalkonium chloride in pigmented rabbits: electrophysiological and morphological studies.
Subconjunctival injection of 0.2 ml of the following solutions was carried out once a day for two weeks in the albino and pigmented rabbit: commercial 0.5% timolol or 1% befunolol ophthalmic solutions, both containing benzalkonium chloride, and also these drug solutions containing no preservative, ophthalmic base solutions containing benzalkonium chloride, physiological saline solution or phosphate buffer solution. One week after daily injections of the commercial drug solutions or base solutions with benzalkonium chloride, the electroretinogram (ERG) showed a marked reduction in the a- and b-wave amplitudes in the pigmented rabbit, but the ERG changes were slight in the albino rabbit. After two weeks of injections, histological studies of the pigmented rabbit eyes revealed retinal detachment, visual cell loss and atrophy of the retinal pigment epithelium and choroid; the changes in the albino rabbit eyes were minimal. Injections of the beta-blockers containing no benzalkonium resulted in no significant changes in the ERG or in the tissue structures of all rabbits. Injections of only physiological saline or phosphate buffer had no deleterious effects. Therefore, the ocular toxicity of the beta-blockers was thought to be minor and the toxic effects seen in this study were thought to be due to benzalkonium chloride, which possibly accumulates in the ocular pigments.
Chou
A
A
Hori
S
S
Takase
M
M
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000378:metabolism / Q000506:poisoning*; D000818:Animals; D001548:Benzalkonium Compounds / Q000009:adverse effects / Q000378:metabolism / Q000506:poisoning*; D004596:Electroretinography; D005123:Eye / Q000187:drug effects* / Q000473:pathology; D005260:Female; D008297:Male; D009887:Ophthalmoscopy; D010857:Pigment Epithelium of Eye / Q000378:metabolism; D011817:Rabbits; D012160:Retina / Q000473:pathology / Q000648:ultrastructure; D012163:Retinal Detachment / Q000139:chemically induced
D000319:Adrenergic beta-Antagonists; D001548:Benzalkonium Compounds